Avita Medical | 1811094D - Selling And Administration Expenses

Stock Price
1.22
Daily Change
-0.01 -0.81%
Monthly
9.91%
Yearly
-57.49%
Q1 Forecast
1.19

Avita Medical reported AUD20.98M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Celltrion KRW 249.98B 16.36B Sep/2025
Clinuvel Pharmaceuticals AUD 9.12M 6.2M Jun/2025
Cochlear AUD 234.95M 235.05M Jun/2025
CSL USD 727M 453M Jun/2025
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Medical Developments International AUD 7.03M 5.91M Jun/2025
Nanosonics AUD 26.85M 23.41M Jun/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Pacific Edge NZD 19.17M 1.32M Dec/2025
Paradigm Biopharmaceuticals AUD 1.61M 747.79K Jun/2025
Pharma Mar EUR 13.7M 983K Sep/2025
Polynovo AUD 21.13M 18.27M Jun/2024
PYC Therapeutics AUD 2.13M 447.24K Jun/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024
Tilray USD 24.85M 1.7M Sep/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025